Search Market Research Report
Oligonucleotide Market Size, Share Global Analysis Report, 2021 - 2026
Oligonucleotide Market By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotide, Reagents, &Equipment), By Application (Research Application & Diagnostic Applications), By End-User (Hospitals, Pharmaceutical & Biological Companies, Diagnostics Laboratories, Contact Manufacturing Organization (CMOs), & Contract Research Organizations (CROs)), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026
Industry Insights
[169+ Pages Report] The report titled “Global Oligonucleotide Market” published by Facts & Factors encompasses the spectacle of the market in an analytical and comprehensive manner. We at Facts & Factors estimate that the global Oligonucleotide Market will be valued at USD 14.6 Billion in the year 2026 from an initial value of USD 6.4 Billion in the year 2020 at a CAGR value of 15.9%.
Market Overview
Oligonucleotide are a form of shorter versions of DNA or RNA molecules and have a wider aspect of applications in the field of genetic testing, research, and forensics to name a few. Oligonucleotide are usually produced in laboratory-based settings by a solid-phase chemical synthesis process and these smaller bits of nucleic acids can be further modified as a single-stranded molecule with any user-specified sequence. These are extremely pivotal for factors pertaining to artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, and molecular cloning.
Industry Growth Factors
The primary driving factors for the significant growth of the global oligonucleotide market can be attributed to the rising use of synthesized oligos in therapeutic application coupled with an increasing focus on personalized medicine to name a few. Additionally, increasing government funding in the field of oligonucleotide coupled with the advent of the COVID-19 pandemic is expected to increase the footprint of the global oligonucleotide market during the forecast period. Rising technological advances coupled with increasing synthetic biology and genome-based projects are expected to boost the global oligonucleotide market during the forecast period.
The global oligonucleotide market is expected to be driven by the increased focus of pharmaceutical and biotechnological companies coupled with increasing applications of synthesized oligonucleotide in the field of molecular diagnostics and clinical solutions to name a few. Factors pertaining to developing highly efficient testing kits and treatment measures and vaccine production are expected to boost the global oligonucleotide market during the forecast period. However, the increasing number of complexities associated with therapeutics oligonucleotide and challenging delivery of consumables is expected to hinder the growth of the global oligonucleotide market to a certain extent.
Segmentation Analysis
The global oligonucleotide market is segmented into product, application, end-user, and regions.
On the basis of product, the global oligonucleotide market is divided into oligonucleotide-based drugs, synthesized oligonucleotide, reagents, and equipment. The oligonucleotide-based drugs segment is expected to witness the largest market share during the advent of the forecast owing to increasing usage of FDA-approved drugs coupled with a rich clinical pipeline of oligonucleotide-based products to name a few. On the basis of application, the global oligonucleotide market can be broken down into research applications and diagnostic applications. The segment pertaining to research application is expected to witness the largest market share during the advent of the forecast owing to increasing usage of oligos as therapeutic agents coupled with increasing integration of the latter into neurological, infectious, and rare diagnostics disorders to name a few. On the basis of end-user, the global oligonucleotide market is fragmented into hospitals, pharmaceutical & biological companies, diagnostics laboratories, contract manufacturing organizations (CMOs), and contract research organizations (CROs). The hospital's category is expected to occupy the largest market share during the advent of the forecast owing to the increasing number of patient and inpatient visits to hospitals coupled with the increasing demand for oligonucleotide drugs owing to the rising number of patients suffering from rare disorders, neurological disorders, and infectious diseases.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 6.4 Billion |
Projected Market Size in 2026 |
USD 14.6 Billion |
CAGR Growth Rate |
15.9% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
Danaher Corporation, Thermo Fischer Scientific, Inc., Merck KGaA, LGC Limited, Maravai Life Sciences, Biogen, Inc., SareptaTherapeutics, Inc., Alnylam Pharmaceuticals, Inc., Eurofins Corporation, Ionis Pharmaceuticals, Inc., Kaneka Corporation, Agilent Technologies, Inc., and G.E Healthcare, among others |
Key Segments |
Products, Applications, End-Users, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
North America is expected to witness the largest market share during the advent of the forecast owing to increasing contribution in theR&D activities of life sciences coupled with rising focus on improving safety and quality of healthcare services to name a few. Additionally, increasing demand from consumers associated with personalized therapeutics coupled with the rising number of key market participants in the region is expected to increase the footprint of the oligonucleotide market during the forecast period. Moreover, the rising number of COVID-19 cases during the peak of the pandemic period coupled with sedentary lifestyle changes is expected to open new revenue opportunities for the oligonucleotide market during the forecast period. The rise in population associated with genetic epidemiology of multifactorial disorders coupled with favorable government policies is expected to boost the oligonucleotide market in the region for a larger consumer base.
Competitive Players
The key market participants for the global oligonucleotide market are:
- Danaher Corporation
- Thermo Fischer Scientific Inc.
- Merck KGaA
- LGC Limited
- Maravai Life Sciences
- Biogen Inc.
- SareptaTherapeutics Inc.
- Alnylam Pharmaceuticals Inc.
- Eurofins Corporation
- Ionis Pharmaceuticals Inc.
- Kaneka Corporation
- Agilent Technologies Inc.
- G.E Healthcare
By Product Segment Analysis
- Oligonucleotide-Based Drugs
- Synthesized Oligonucleotide
- Reagents
- Equipment
By Application Segment Analysis
- Research Application
- PCR
- Sequencing
- Others
- Diagnostic Applications
By End-User Segment Analysis
- Hospitals
- Pharmaceutical & Biological Companies
- Diagnostics Laboratories
- Contact Manufacturing Organization (CMOs)
- Contract Research Organizations (CROs)
Table of Content
Industry Major Market Players
- Danaher Corporation
- Thermo Fischer Scientific Inc.
- Merck KGaA
- LGC Limited
- Maravai Life Sciences
- Biogen Inc.
- SareptaTherapeutics Inc.
- Alnylam Pharmaceuticals Inc.
- Eurofins Corporation
- Ionis Pharmaceuticals Inc.
- Kaneka Corporation
- Agilent Technologies Inc.
- G.E Healthcare
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors